Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Cardiovascular events in adults taking medications for ADHD.

Devlin JJ, Punja M, Kazzi ZN.

JAMA. 2012 Apr 11;307(14):1485-6; author reply 1486. doi: 10.1001/jama.2012.448. No abstract available.

PMID:
22496258
[PubMed - indexed for MEDLINE]
2.

ADHD medications and cardiovascular risk: some heartening news.

Shaw P.

JAMA. 2011 Dec 28;306(24):2723-4. doi: 10.1001/jama.2011.1866. Epub 2011 Dec 12. No abstract available.

PMID:
22161945
[PubMed - indexed for MEDLINE]
3.

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.

Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham TC, Quinn VP, Dublin S, Boudreau DM, Andrade SE, Pawloski PA, Raebel MA, Smith DH, Achacoso N, Uratsu C, Go AS, Sidney S, Nguyen-Huynh MN, Ray WA, Selby JV.

JAMA. 2011 Dec 28;306(24):2673-83. doi: 10.1001/jama.2011.1830. Epub 2011 Dec 12.

PMID:
22161946
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Adult attention-deficit/hyperactivity disorder treatment and cardiovascular implications.

Hammerness PG, Surman CB, Chilton A.

Curr Psychiatry Rep. 2011 Oct;13(5):357-63. doi: 10.1007/s11920-011-0213-3. Review.

PMID:
21698412
[PubMed - indexed for MEDLINE]
5.

Stimulant medications and attention deficit-hyperactivity disorder.

Cohen AL, Jhung MA, Budnitz DS.

N Engl J Med. 2006 May 25;354(21):2294-5. No abstract available.

PMID:
16723627
[PubMed - indexed for MEDLINE]
Free Article
6.

Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.

Martinez-Raga J, Knecht C, Szerman N, Martinez MI.

CNS Drugs. 2013 Jan;27(1):15-30. doi: 10.1007/s40263-012-0019-9. Review.

PMID:
23160939
[PubMed - indexed for MEDLINE]
7.

Safety of stimulant treatment in attention deficit hyperactivity disorder: part II.

Merkel RL.

Expert Opin Drug Saf. 2010 Nov;9(6):917-35. doi: 10.1517/14740338.2010.503238. Review.

PMID:
20615078
[PubMed - indexed for MEDLINE]
8.

Medications for attention deficit hyperactivity disorder: cardiovascular concerns.

Wooltorton E.

CMAJ. 2006 Jul 4;175(1):29. Epub 2006 Jun 13. No abstract available.

PMID:
16772535
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Update on adult attention-deficit/hyperactivity disorder.

Hammerness P, Surman C, Miller K.

Curr Neurol Neurosci Rep. 2008 Nov;8(6):484-9.

PMID:
18957185
[PubMed - indexed for MEDLINE]
10.

Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study.

Hennessy S, Schelleman H, Daniel GW, Bilker WB, Kimmel SE, Guevara J, Cziraky MJ, Strom BL.

Pharmacoepidemiol Drug Saf. 2010 Sep;19(9):934-41. doi: 10.1002/pds.1992.

PMID:
20623519
[PubMed - indexed for MEDLINE]
11.

[Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].

Golubchik P, Sever J, Weizman A.

Harefuah. 2011 Oct;150(10):788-90, 814. Review. Hebrew.

PMID:
22111124
[PubMed - indexed for MEDLINE]
12.

ADHD drugs and cardiovascular risk.

Anders T, Sharfstein S.

N Engl J Med. 2006 May 25;354(21):2296-8; author reply 2296-8. No abstract available.

PMID:
16723628
[PubMed - indexed for MEDLINE]
Free Article
13.

FDA ponders cardiovascular risks of ADHD drugs.

Young D.

Am J Health Syst Pharm. 2006 Mar 15;63(6):492-4. No abstract available.

PMID:
16522874
[PubMed - indexed for MEDLINE]
14.

ADHD drugs and serious cardiovascular events in children and young adults.

Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA.

N Engl J Med. 2011 Nov 17;365(20):1896-904. doi: 10.1056/NEJMoa1110212. Epub 2011 Nov 1.

PMID:
22043968
[PubMed - indexed for MEDLINE]
Free Article
15.

Encouraging news about ADHD drugs and heart risk in adults.

[No authors listed]

Harv Ment Health Lett. 2012 Mar;28(9):7. No abstract available.

PMID:
22474711
[PubMed - indexed for MEDLINE]
16.
17.

Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.

Santosh PJ, Sattar S, Canagaratnam M.

CNS Drugs. 2011 Sep 1;25(9):737-63. doi: 10.2165/11593070-000000000-00000. Review.

PMID:
21870887
[PubMed - indexed for MEDLINE]
18.

Cardiovascular events and methylphenidate use in Taiwan.

Tai YM, Gau SS, Gau CS.

J Am Acad Child Adolesc Psychiatry. 2012 Mar;51(3):324-5; author reply 325-6. doi: 10.1016/j.jaac.2011.12.011. No abstract available.

PMID:
22365468
[PubMed - indexed for MEDLINE]
19.

ADHD drugs and cardiovascular risk.

Rappley MD, Moore JW, Dokken D.

N Engl J Med. 2006 May 25;354(21):2296-8; author reply 2296-8. No abstract available.

PMID:
16729375
[PubMed - indexed for MEDLINE]
20.

Stimulants for kids with ADHD--how to proceed safely.

Ken Mehta S, Jacobs I.

J Fam Pract. 2014 Feb;63(2):E1-5.

PMID:
24527478
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk